Adherence to Healthy Lifestyle Prior to Infection and Risk of Post–COVID-19 Condition

Siwen Wang; Yanping Li; Yiyang Yue; Changzheng Yuan; Jae Hee Kang; Jorge E Chavarro; Shilpa N Bhupathiraju; Andrea L Roberts

doi:10.1001/jamainternmed.2022.6555

. 2023 Feb 6;183(3):232–241. doi: 10.1001/jamainternmed.2022.6555

Adherence to Healthy Lifestyle Prior to Infection and Risk of Post–COVID-19 Condition

Siwen Wang ^1,^✉, Yanping Li ¹, Yiyang Yue ¹, Changzheng Yuan ^1,², Jae Hee Kang ³, Jorge E Chavarro ^1,^3,⁴, Shilpa N Bhupathiraju ^1,³, Andrea L Roberts ⁵

¹Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts

²Zhejiang University School of Public Health, Hangzhou, China

³Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts

⁴Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts

⁵Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts

Accepted for Publication: December 4, 2022.

Published Online: February 6, 2023. doi:10.1001/jamainternmed.2022.6555

^✉

Corresponding Author: Siwen Wang, MD, Department of Nutrition; Harvard T.H. Chan School of Public Health, 655 Huntington Ave, Building 2, Room 316, Boston, MA 02215 (siwenwang@hsph.harvard.edu).

Author Contributions: Dr Wang had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Concept and design: Wang, Chavarro, Roberts.

Acquisition, analysis, or interpretation of data: All authors.

Drafting of the manuscript: Wang.

Critical revision of the manuscript for important intellectual content: All authors.

Statistical analysis: Wang, Li, Yue, Yuan, Bhupathiraju, Roberts.

Obtained funding: Chavarro, Roberts.

Administrative, technical, or material support: Yue, Chavarro.

Supervision: Kang, Chavarro, Roberts.

Conflict of Interest Disclosures: Dr Kang reported grants from Pfizer outside the submitted work and National Institutes of Health (NIH) during the conduct of the study. Dr Bhupathiraju reported personal fees from LayerIV outside the submitted work. No other disclosures were reported.

Funding/Support: This research was supported by NIH National Institute of Child Health and Human Development grant 3R01HD094725-02S1 (to A.L.R.). Other support includes grants U01HL145386, R24ES028521, U01 CA176726, R01 CA67262, and R01 HD057368 from the NIH, the Dean’s Fund for Scientific Advancement Acceleration Award from the Harvard T.H. Chan School of Public Health, and Massachusetts Consortium on Pathogen Readiness Evergrande COVID-19 Response Fund Award.

Role of the Funder/Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Additional Information: Further information including the procedures to obtain and access data from the Nurses’ Health Studies is described at https://www.nurseshealthstudy.org/researchers (contact email: nhsaccess@channing.harvard.edu).

Data Sharing Statement: See Supplement 2.

^✉

Corresponding author.

PMCID: PMC9989904 PMID: 36745445

Key Points

Question

Is a healthy lifestyle (healthy body mass index, never smoking, high-quality diet, moderate alcohol intake, regular exercise, and adequate sleep) prior to SARS-CoV-2 infection protective of post–COVID-19 condition (PCC)?

Findings

In this prospective cohort study of 1981 women who reported a positive SARS-CoV-2 test from April 2020 to November 2021, adherence to a healthy lifestyle prior to infection was inversely associated with risk of PCC in a dose-dependent manner. Compared with those who did not have any healthy lifestyle factors, those with 5 or 6 had half the risk of PCC.

Meaning

Preinfection healthy lifestyle was associated with a substantially decreased risk of PCC.

Abstract

Importance

Few modifiable risk factors for post–COVID-19 condition (PCC) have been identified.

Objective

To investigate the association between healthy lifestyle factors prior to SARS-CoV-2 infection and risk of PCC.

Design, Setting, and Participants

In this prospective cohort study, 32 249 women in the Nurses’ Health Study II cohort reported preinfection lifestyle habits in 2015 and 2017. Healthy lifestyle factors included healthy body mass index (BMI, 18.5-24.9; calculated as weight in kilograms divided by height in meters squared), never smoking, at least 150 minutes per week of moderate to vigorous physical activity, moderate alcohol intake (5 to 15 g/d), high diet quality (upper 40% of Alternate Healthy Eating Index–2010 score), and adequate sleep (7 to 9 h/d).

Main Outcomes and Measures

SARS-CoV-2 infection (confirmed by test) and PCC (at least 4 weeks of symptoms) were self-reported on 7 periodic surveys administered from April 2020 to November 2021. Among participants with SARS-CoV-2 infection, the relative risk (RR) of PCC in association with the number of healthy lifestyle factors (0 to 6) was estimated using Poisson regression and adjusting for demographic factors and comorbidities.

Results

A total of 1981 women with a positive SARS-CoV-2 test over 19 months of follow-up were documented. Among those participants, mean age was 64.7 years (SD, 4.6; range, 55-75); 97.4% (n = 1929) were White; and 42.8% (n = 848) were active health care workers. Among these, 871 (44.0%) developed PCC. Healthy lifestyle was associated with lower risk of PCC in a dose-dependent manner. Compared with women without any healthy lifestyle factors, those with 5 to 6 had 49% lower risk (RR, 0.51; 95% CI, 0.33-0.78) of PCC. In a model mutually adjusted for all lifestyle factors, BMI and sleep were independently associated with risk of PCC (BMI, 18.5-24.9 vs others, RR, 0.85; 95% CI, 0.73-1.00, P = .046; sleep, 7-9 h/d vs others, RR, 0.83; 95% CI, 0.72-0.95, P = .008). If these associations were causal, 36.0% of PCC cases would have been prevented if all participants had 5 to 6 healthy lifestyle factors (population attributable risk percentage, 36.0%; 95% CI, 14.1%-52.7%). Results were comparable when PCC was defined as symptoms of at least 2-month duration or having ongoing symptoms at the time of PCC assessment.

Conclusions and Relevance

In this prospective cohort study, pre-infection healthy lifestyle was associated with a substantially lower risk of PCC. Future research should investigate whether lifestyle interventions may reduce risk of developing PCC or mitigate symptoms among individuals with PCC or possibly other postinfection syndromes.

This prospective cohort study investigates the association between healthy lifestyle factors prior to SARS-CoV-2 infection and risk of post–COVID-19 condition.

Introduction

Post–COVID-19 condition (PCC), informally known as long COVID, is defined as having COVID-19 symptoms for at least 4 weeks after initial SARS-CoV-2 infection.¹ This condition is estimated to affect 20% to 40% of individuals with COVID-19.^2,3 The prevalence is higher among persons who were not vaccinated against COVID-19 or who were hospitalized for COVID-19 during the acute phase, reaching 50% to 70%.^4,5,6 The condition has a wide range of respiratory, cardiovascular, metabolic, gastrointestinal, neurological, and psychiatric manifestations, which can influence daily functioning.⁷ With ongoing waves of SARS-CoV-2 infection, PCC has created a serious public health burden, with an estimated 8 to 23 million Americans having developed PCC.⁸ Thus, better understanding of PCC causes is critical.

Persistent inflammation has been implicated in PCC symptoms related to multiple organs.^9,10 Inflammatory factors have also been associated with other postinfection syndromes, such as postviral fatigue syndrome.^11,12 Healthy lifestyle factors, including healthy body mass index (BMI; calculated as weight in kilograms divided by height in meters squared),¹³ abstinence from cigarette smoking,¹⁴ a healthy diet,¹⁵ moderate alcohol consumption,¹⁶ regular exercise,¹⁷ and adequate sleep,¹⁸ have been identified as protective against inflammation. Adherence to multiple healthy lifestyle factors is associated with less severe COVID-19 disease as well as lower mortality from infectious diseases (including COVID-19), in a dose-dependent manner.^19,20

Prior studies have found healthy BMI was associated with lower risk of PCC and inconsistent associations between smoking and PCC.^21,22,23 The association between multiple healthy lifestyle factors prior to infection and risk of PCC has not been established.

In this prospective cohort study, we investigated the association of adherence to modifiable risk factors prior to infection (eg, healthy BMI, never smoking, healthy diet, moderate alcohol consumption, regular exercise, and adequate sleep) with the risk of developing PCC among participants subsequently infected with SARS-CoV-2. We further examined the extent to which established risk factors for COVID-19 severity (eg, hypertension, asthma)^21,24 might account for possible associations. In addition, among individuals with PCC, we explored whether preinfection healthy lifestyle was associated with number of PCC symptoms and PCC-related daily life impairment.

Methods

Participants were from an ongoing longitudinal cohort, the Nurses’ Health Study II, which in 1989 enrolled 116 429 female nurses residing in the US aged 25 to 42 years.²⁵ Biennial follow-up questionnaires are sent to query lifestyle characteristics and health. Response rates exceeded 85% at each follow-up cycle. In April 2020 (termed baseline henceforth), a COVID-19 substudy invitation was sent to active cohort participants to assess health during the pandemic, with monthly and quarterly follow-up surveys administered through November 2021 (55 925 invited, 39 137 [71%] responded) (eFigure 1 in the Supplement).

Of women who responded to the COVID-19 substudy baseline and final questionnaires, 32 249 women had returned the 2017 biennial questionnaire querying lifestyle factors. During 19 months of follow-up, 2303 participants (7.1%) reported a positive SARS-CoV-2 test (antibody, antigen, or PCR [polymerase chain reaction]) and the date of that test. In main analyses, we excluded 89 participants who did not have complete information about lifestyle factors and 233 participants who did not answer the PCC question, leaving 1981 participants (eFigure 2 in the Supplement).

The study was approved by the Brigham and Women's Hospital institutional review board. Return of questionnaires implied informed consent. Results are reported in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline.

Assessment of Healthy Lifestyle

Six potentially modifiable lifestyle factors were assessed, including BMI, smoking, alcohol consumption, diet, physical activity, and sleep (2015 for diet and alcohol intake, 2017 for others). Self-report of weight and height has been validated in this cohort.²⁶ Smoking was queried every 2 years, and we characterized lifetime smoking history as never, past, or current smoking. In a validation study, toenail nicotine level was strongly associated with reported smoking level (Spearman r, 0.63).²⁷ Diet in the past year was measured using a validated semiquantitative food frequency questionnaire (FFQ).^28,29 To characterize overall diet quality, we used the Alternative Healthy Eating Index (AHEI-2010), which is based on empirical evidence³⁰ (higher score indicates healthier diet), excluding the alcohol component. Alcoholic beverage consumption was also collected by the FFQ. Physical activity was assessed using a validated questionnaire.³¹ For each participant, we estimated the average time spent in the past year in moderate to vigorous recreational activities (eg, running, jogging, cycling, tennis, squash, racquet ball, swimming, weight or resistance training, brisk walking, and other vigorous activities). We queried average sleep in a 24-hour period, with response options ranging from less than 5 to at least 10 hours. Daily sleep duration has been validated.³²

Healthy Lifestyle Score

We defined 6 healthy lifestyle factors as healthy body weight (BMI, 18.5-24.9), never smoking, at least 150 minutes per week of moderate to vigorous physical activity, high diet quality (upper 40% of AHEI-2010 score), moderate alcohol intake (5-15 g/d), and adequate sleep (7-9 h/d), in accordance with US government recommendations or prior evidence.^33,34,35,36

For each of the 6 factors, we created a binary variable, with participants receiving a score of 1 if they met the criteria for healthy and 0 otherwise. We then calculated the total number of healthy lifestyle factors for each participant. Because only 36 women had all 6 healthy lifestyle factors, women with 5 or 6 factors were combined in analyses.

SARS-CoV-2 Infection and PCC

SARS-CoV-2 infection and PCC ascertainment in this cohort has been described elsewhere.³⁷ Briefly, past 7-day, 30-day, and 90-day positive SARS-CoV-2 test (antibody, antigen, or PCR) and hospitalization due to COVID-19 since March 1, 2020, were self-reported on each follow-up questionnaire in the COVID-19 substudy. Post–COVID-19 condition was assessed on the final substudy questionnaire, administered 12 months after baseline. Participants were asked, “Have you experienced any long-term COVID-19 symptoms (lasting for more than 4 weeks)?” If yes, participants were asked to indicate which symptoms they experienced (eMethods in the Supplement). Participants with self-reported PCC were asked: (1) whether symptoms were ongoing; (2) duration of symptoms (less than 2 months; 2-3 months; 4-5 months); and (3) how often the symptoms prevented them from carrying out daily activities.

Covariates

Date of birth (ascertained in 1989), racial and ethnic group (1989), and partner’s educational attainment (1999) were self-reported. Census tract median income and percentage with bachelor’s degree or higher were assessed based on geocoded residence in 2009. Lifetime history of physician-diagnosed diseases has been updated biennially (eMethods in the Supplement). Frontline health care worker status was self-reported at COVID-19 substudy baseline. COVID-19 vaccination status and date of vaccination were assessed on quarterly follow-up questionnaires.

Statistical Analysis

Among participants who reported a positive SARS-CoV-2 test over follow-up, we first compared sociodemographic factors and distribution of preinfection healthy lifestyle factors among those who responded to the PCC question vs those who did not. We then compared the prevalence of sociodemographic and lifestyle factors by the number of healthy lifestyle factors. Each variable was missing less than 5%. Indicator variables were used for any missing covariate information for categorical variables; no participants were missing data for continuous variables.

We estimated the relative risks (RRs) and 95% CIs for the associations between the healthy lifestyle score and risk of PCC, adjusting for age, race and ethnicity, partners’ education, census tract median household income, census tract percentage population with bachelor’s degree or higher, health care worker status, and history of chronic diseases (fully adjusted model) using Poisson regression. We also estimated the RRs and 95% CIs for the associations between individual healthy lifestyle factors (both as categorical/continuous variables and dichotomized) with risk of PCC. We further fit models mutually adjusted for all healthy lifestyle factors. In addition, we calculated the population attributable risk percentage (PAR). PAR estimates the proportion of PCC in this cohort that hypothetically would not have occurred if effect estimates reflected causal relationships and all participants were in the low-risk group.³⁸ To calculate the PAR, we used RRs and 95% CIs from the fully adjusted model including all 6 healthy lifestyle factors.

To estimate the PAR in the US population, we used the prevalence of the 6 lifestyle factors among women of the same age as our study (ages 55-75 years) in the nationally representative US National Health and Nutrition Examination Survey (NHANES, 2013-2014). Further, among persons who developed PCC, we compared frequency of PCC symptoms and daily-life impairment due to PCC by healthy lifestyle score.

We conducted 10 sensitivity analyses. First, we defined PCC as having symptoms lasting for more than 2 months and more than 4 months. Second, as not all participants may have had access to testing, we expanded the definition of SARS-CoV-2 infection to include participants having symptoms without a confirmed test (926 COVID-19 cases were added). Third, to investigate whether the observed associations were explained by the severity of acute phase disease, we excluded participants who had been hospitalized due to COVID-19. Fourth, we used multiple imputation for missing healthy lifestyle (n = 89) or PCC (n = 233) information. Fifth, to reduce possible recall bias, we restricted PCC cases to 633 participants who reported ongoing symptoms at the time of PCC assessment. Sixth, to distinguish PCC symptoms from symptoms related to sleep deprivation, we excluded participants reporting only psychological, cognitive, or neurological symptoms. Seventh, we excluded 497 persons reporting fatigue as one of their long-term symptoms (among whom 48 reported fatigue as their only symptom). Eighth, because risk of PCC may be reduced among those who were vaccinated against COVID-19, we additionally adjusted for vaccination status at time of infection.⁶ Ninth, as low-to-moderate vs no alcohol consumption has been associated with both better and worse health,^39,40 we excluded alcohol from the healthy lifestyle score. Tenth, we investigated whether observed associations differed by health care worker status by adding a cross-product term to the model. All analyses were conducted in SAS statistical software, version 9.4 (SAS Institute). All statistical tests were 2-sided. Significance level was assessed at P < .05.

Results

The mean (SD) age of 32 249 participants was 65.9 (4.5) years (range 55-75 years). Of those, 97.2% were White, and 28.7% were active health care workers. Participants missing PCC data (n = 233) (vs those nonmissing [n = 1981]) were more likely to be racial and ethnic minorities, have lower BMI, be health care workers, have higher socioeconomic status, sleep less, and be less likely to have type 2 diabetes (eTable 1 in the Supplement). We documented 1981 participants with a positive SARS-CoV-2 test over 19 months of follow-up. Among those participants, mean age was 64.7 years (SD, 4.6; range, 55-75); 97.4% (n = 1929) were White; and 42.8% (n = 848) were active health care workers. The median time from assessment of exposures (return of 2017 questionnaire) to SARS-CoV-2 infection was 35 months (IQR, 31 months-37 months).

Healthy lifestyle factors were weakly to moderately correlated with each other (Φ coefficient range, −0.03 to 0.24; eTable 2 in the Supplement). At baseline, those who had greater healthy lifestyle scores were younger, more likely to be White, had higher socioeconomic status, and had lower prevalence of comorbidities (Table 1). Of participants who reported a positive SARS-CoV-2 test during follow-up, 44.0% (n = 871) reported PCC. Among these, 87.0% (n = 758) reported symptoms lasting at least 2 months, and 56.5% (n = 491) reported at least occasional daily life impairment related to PCC. The most common symptoms were fatigue (57.1%, n = 497), smell or taste problems (40.9%, n = 356), shortness of breath (25.3%, n = 220), confusion/disorientation/brain fog (21.6%, n = 188), and memory issues (20.0%, n = 174).

Table 1. Age-Standardized Participant Characteristics by Number of Healthy Lifestyle Factors Prior to the Pandemic Among Participants Who Reported a Positive SARS-CoV-2 Test During Follow-up, the Nurses’ Health Study II, 2015-2021^a.

Characteristic	No. (%) (n = 1981)
	No. of healthy lifestyle factors
	0 (n = 66)	1 (n = 301)	2 (n = 564)	3 (n = 518)	4 (n = 344)	5 or 6 (n = 188)
Age, mean (SD), y^b	65.8 (4.3)	65.2 (4.5)	65.1 (4.6)	64.3 (4.7)	64.4 (4.4)	64.0 (4.7)
Race, White^c	64 (96.8)	291 (96.8)	554 (98.2)	495 (95.5)	338 (98.3)	187 (99.5)
Partner’s education ≤ high school	14 (21.8)	60 (19.8)	108 (19.1)	77 (14.8)	37 (10.7)	13 (7.1)
Census tract median household income, mean (SD), USD	56 248 (17 550.8)	59 814.9 (19 479.1)	63 283.7 (22 513.7)	66 416.3 (25 742.1)	69 275.8 (26 415.7)	71 252.7 (26 143.9)
Census tract % population with bachelor’s degree or higher, mean (SD)	24.0 (14.9)	24.7 (13.8)	28.6 (15.9)	31.8 (17.8)	35.0 (17.7)	36.7 (18.6)
BMI, mean (SD)	32.5 (8.7)	32.6 (6.4)	30.2 (6.4)	27.3 (5.9)	25.3 (4.4)	22.8 (2.6)
AHEI, mean (SD)	52.1 (8.4)	53.4 (10)	56.8 (10.3)	62.1 (11.7)	66.7 (10.9)	72.6 (8.5)
Alcohol, mean (SD), g/d	4.0 (9.7)	6.2 (14)	6.7 (12)	7.9 (11.7)	7.2 (8.5)	9.4 (7.7)
Physical activity, min/wk	24.0 (33.0)	63.3 (153.9)	131 (258.9)	266.8 (318.5)	373.7 (339.5)	478 (402.2)
Sleep, h/d
≤5	11 (16.7)	40 (13.3)	56 (10.0)	28 (5.5)	15 (4.2)	0 (0.0)
6	51 (77.5)	154 (51.0)	116 (20.6)	107 (20.6)	43 (12.4)	8 (4.0)
7	0 (0)	53 (17.7)	213 (37.8)	231 (44.6)	193 (56.2)	101 (53.8)
8	0 (0)	38 (12.7)	137 (24.4)	122 (23.5)	80 (23.3)	72 (38.4)
9	0 (0)	6 (2.1)	37 (6.6)	26 (5.0)	13 (3.8)	7 (3.7)
≥10	4 (5.8)	9 (3.1)	4 (0.7)	4 (0.8)	0 (0.0)	0 (0.0)
Smoking
Never	0 (0.0)	129 (42.7)	360 (63.9)	367 (70.9)	280 (81.4)	175 (92.9)
Past	58 (87.6)	161 (53.6)	185 (32.9)	146 (28.3)	63 (18.3)	13 (7.1)
Current	8 (12.4)	11 (3.7)	18 (3.2)	4 (0.8)	1 (0.3)	0 (0.0)
Frontline health care worker^d	26 (38.8)	138 (45.7)	259 (45.9)	221 (42.7)	135 (39.4)	73 (38.8)
Lifetime history of comorbidities
High cholesterol	52 (79.4)	199 (66.1)	349 (61.8)	318 (61.4)	193 (56.1)	92 (49.1)
Diabetes	18 (27.4)	64 (21.2)	80 (14.3)	46 (8.9)	15 (4.3)	5 (2.4)
Hypertension	42 (64.3)	177 (58.7)	276 (48.9)	205 (39.6)	103 (30.1)	45 (23.9)
Asthma	23 (35.5)	83 (27.5)	144 (25.6)	112 (21.6)	56 (16.2)	33 (17.7)
Cancer	18 (28.0)	77 (25.4)	103 (18.3)	101 (19.4)	81 (23.4)	35 (18.7)
Chronic obstructive pulmonary disease	12 (18.7)	22 (7.3)	28 (5.0)	22 (4.2)	10 (2.9)	2 (1.3)
Cardiovascular disease^e	12 (18.3)	45 (14.8)	50 (8.9)	53 (10.2)	17 (5.0)	2 (1.3)
Inflammatory bowel disease	2 (3.6)	8 (2.7)	21 (3.7)	13 (2.5)	9 (2.6)	2.6 (5)
Hospitalization due to COVID-19	8 (12.0)	23 (7.8)	36 (6.4)	21 (4.0)	6 (1.6)	5 (2.6)
COVID-19 vaccination (first dose) by the time of infection	6 (9.5)	15 (5.0)	38 (6.7)	35 (6.8)	24 (6.9)	7 (3.6)

Open in a new tab

Abbreviations: AHEI, Alternative Healthy Eating Index; BMI, body mass index (calculated as weight in kilograms divided by height in meters squared).

^{^a}

Healthy lifestyle factors include healthy body weight (BMI, 18.5-24.9), never smoking, at least 150 min/wk of moderate to vigorous physical activity, high diet quality (upper 40% of AHEI-2010 score), moderate alcohol intake (5-15 g/d), and adequate sleep (7-9 h/d). Diet and alcohol intake were assessed in 2015, all other lifestyle factors were assessed in 2017.

^{^b}

Not age-standardized.

^{^c}

Race and ethnicity were self-reported at cohort entry. Values for categories other than White (American Indian/Alaska Native, Asian, Black or African American, Native Hawaiian or Pacific Islander, and other) are not presented because their number were small.

^{^d}

Defined as physically working at a site providing clinical care.

^{^e}

Included angina, coronary artery bypass graft, myocardial infarction, stroke, and deep vein thrombosis.

Risk of PCC was lower with increasing number of healthy lifestyle factors (Figure 1; P < .001 for trend). Compared with women who did not adhere to any healthy lifestyle factors, those having 5 or 6 factors had a 49% lower risk of PCC (RR, 0.51; 95% CI, 0.33-0.78, Figure 1). Assuming a causal relationship, the PAR for healthy lifestyle was 36.0% (95% CI, 14.1%-52.7%).

In analyses examining each healthy lifestyle factor separately, BMI, smoking, diet, and physical activity were associated with risk of PCC in models adjusting for demographic factors (Table 2, Model 1). Compared to low or high levels, moderate alcohol consumption and 7 to 9 h/d sleep had the lowest risk of PCC (Table 2, Model 1). When further adjusted for socioeconomic status, health care worker status, and comorbidities, the associations were slightly attenuated (Table 2, Model 2). When we categorized the 6 lifestyle factors as binary variables, BMI and sleep were independently associated with risk of PCC in models mutually adjusted for all factors (Table 2, Model 3; Table 3). If these relationships were causal, the PAR (95% CI) for overweight/obesity was 10.3% (95% CI, 0.2%-19.8%) and for inadequate sleep was 6.6% (95% CI, 1.8%-11.5%, Table 3). PARs for other healthy lifestyle factors ranged from 2.4% to 4.5%. Results were comparable when we used the prevalence of healthy lifestyle factors in NHANES for PAR calculation (eTable 3 in the Supplement).

Table 2. Healthy Lifestyle Factors Prior to the Pandemic and Risk of Post–COVID-19 Condition (PCC) Among Participants Who Reported a Positive SARS-CoV-2 Test During Follow-up, the Nurses’ Health Study II, 2015-2021.

Characteristic	PCC/total COVID (n = 1981)	Relative risk (95% CI)
Characteristic	PCC/total COVID (n = 1981)	Model 1: Adjusted for age, race and ethnicity, and socioeconomic status^a	Model 2: Further adjusted for health care worker status and history of chronic diseases^b	Model 3: Model 2, mutually adjusted for other healthy lifestyle factors^c
BMI
<18.5	12/24	1.37 (0.77-2.45)	1.35 (0.76-2.43)	1.31 (0.73-2.34)
18.5-24.9	249/665	1 [Reference]	1 [Reference]	1 [Reference]
25-29.9	265/619	1.15 (0.97-1.37)	1.12 (0.94-1.33)	1.11 (0.93-1.32)
30-34.9	201/392	1.38 (1.14-1.66)	1.30 (1.07-1.58)	1.27 (1.04-1.55)
≥35	144/281	1.35 (1.09-1.67)	1.25 (1.00-1.56)	1.21 (0.96-1.52)
P for trend	NA	.001	.02	.04
Smoking
Never	550/1309	1 [Reference]	1 [Reference]	1 [Reference]
Past	302/631	1.14 (0.99-1.31)	1.10 (0.96-1.27)	1.11 (0.96-1.29)
Current	19/41	1.09 (0.69-1.72)	1.04 (0.65-1.64)	1.02 (0.64-1.63)
P for trend	NA	.10	.23	.22
Diet^d
Q1	218/480	1 [Reference]	1 [Reference]	1 [Reference]
Q2	194/427	1.01 (0.83-1.22)	1.01 (0.83-1.22)	1.03 (0.85-1.26)
Q3	186/409	1.02 (0.84-1.24)	1.04 (0.85-1.27)	1.08 (0.88-1.32)
Q4	149/347	0.95 (0.77-1.18)	0.97 (0.79-1.21)	1.03 (0.83-1.28)
Q5	124/318	0.87 (0.69-1.09)	0.91 (0.72-1.14)	0.97 (0.77-1.23)
P for trend^e	NA	.23	.44	.82
Alcohol consumption, g/d
0	295/631	1.14 (0.94-1.37)	1.10 (0.92-1.33)	1.08 (0.89-1.30)
1.0–4.9	262/583	1.10 (0.91-1.32)	1.10 (0.91-1.33)	1.07 (0.88-1.29)
5.0–14.9	191/468	1 [Reference]	1 [Reference]	1 [Reference]
15.0–29.9	77/202	0.94 (0.72-1.23)	0.94 (0.72-1.23)	0.94 (0.72-1.23)
≥30	46/97	1.17 (0.85-1.62)	1.14 (0.83-1.58)	1.15 (0.83-1.59)
Moderate and vigorous physical activity, min/wk
0–30	283/594	1.19 (1.01-1.41)	1.12 (0.94-1.33)	1.06 (0.88-1.27)
30–90	165/354	1.17 (0.96-1.42)	1.14 (0.93-1.38)	1.09 (0.89-1.33)
90–150	62/139	1.10 (0.83-1.45)	1.10 (0.83-1.45)	1.08 (0.81-1.43)
150–210	87/203	1.08 (0.85-1.37)	1.06 (0.83-1.35)	1.04 (0.81-1.32)
≥210	274/691	1 [Reference]	1 [Reference]	1 [Reference]
P for trend	NA	.03	.17	.41
Sleep duration, h/d
≤5	75/146	1.25 (0.97-1.61)	1.18 (0.92-1.53)	1.18 (0.91-1.52)
6	245/480	1.25 (1.06-1.47)	1.21 (1.02-1.43)	1.21 (1.02-1.43)
7	325/794	1 [Reference]	1 [Reference]	1 [Reference]
8	177/450	0.96 (0.80-1.16)	0.97 (0.80-1.16)	0.96 (0.80-1.16)
9	39/90	1.07 (0.77-1.49)	1.01 (0.72-1.42)	0.99 (0.71-1.39)
≥10	10/21	1.14 (0.60-2.14)	1.11 (0.59-2.09)	1.07 (0.56-2.04)

Open in a new tab

Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); NA, not applicable; Q, quintile.

^{^a}

Model 1: Adjusted for age, race and ethnicity, partner’s education, census tract median household income, and census tract percentage population with bachelor’s degree or higher.

^{^b}

Model 2: Model 1 + health care working status and history of chronic obstructive pulmonary disease, cancer, diabetes, asthma, hypertension, high cholesterol, cardiovascular diseases, and inflammatory bowel disease.

^{^c}

Model 3: Model 2 + mutual adjustment for other lifestyle factors.

^{^d}

Diet measured as Alternative Healthy Eating Index (AHEI)–2010 score. Diet and alcohol intake were assessed in 2015; all other lifestyle factors were assessed in 2017.

^{^e}

P for trend analysis used indicator levels as a continuous variable.

Table 3. Dichotomized Healthy Lifestyle Factors Prior to the Pandemic and Risk of Post–COVID-19 Condition (PCC) Among Participants Who Reported a Positive SARS-CoV-2 Test During Follow-up, the Nurses’ Health Study II, 2015-2021.

Healthy lifestyle factors	PCC/total COVID (n = 1981)	Relative risk^a (95% CI)	Relative risk^b (95% CI)	Population attributable risk percentage^b (95% CI)
BMI
<18.5 or ≥25	622/1316	1 [Reference]	1 [Reference]
18.5-24.9	249/665	0.79 (0.68-0.92)	0.85 (0.73-1.00)	10.3 (0.2-19.8)
Smoking
Past or current	321/672	1 [Reference]	1 [Reference]
Never	550/1309	0.88 (0.77-1.01)	0.91 (0.79-1.05)	3.0 (–1.8-8.0)
Diet^c
Lower 60%	598/1316	1 [Reference]	1 [Reference]
Upper 40%	273/665	0.90 (0.78-1.05)	0.97 (0.83-1.12)	2.4 (–7.6-11.9)
Alcohol consumption, g/d
<5 or >15	680/1513	1 [Reference]	1 [Reference]
Moderate (5-15)	191/468	0.91 (0.77-1.07)	0.94 (0.80-1.11)	4.5 (–8.1-16.0)
Moderate/vigorous exercise, min/wk
<150	510/1087	1 [Reference]	1 [Reference]
≥150	397/965	0.86 (0.76-1.00)	0.94 (0.81-1.08)	3.4 (–4.5-11.2)
Sleep duration, h/d
<7 or >9	330/647	1 [Reference]	1 [Reference]
7-9	541/1334	0.80 (0.69-0.92)	0.83 (0.72-0.95)	6.6 (1.8-11.5)

Open in a new tab

Abbreviation: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared).

^{^a}

Adjusted for age, race and ethnicity, partner’s education, census tract median household income, and census tract percentage population with bachelor’s degree or higher.

^{^b}

Adjusted for age; race and ethnicity; health care working status; partner’s education, census tract median household income; census tract percentage population with bachelor’s degree or higher; history of chronic obstructive pulmonary disease, cancer, diabetes, asthma, hypertension, high cholesterol, cardiovascular diseases, and inflammatory bowel disease; and other lifestyle factors included in the table. Reference group for relative risk calculation is all other COVID-19 cases not in low risk factor category as defined in table.

^{^c}

Diet measured as Alternative Healthy Eating Index (AHEI)–2010 score. Diet and alcohol intake were assessed in 2015; all other lifestyle factors were assessed in 2017.

Results were similar in sensitivity analyses defining PCC as having symptoms lasting at least 2 months or at least 4 months; including self-presumed COVID-19 cases; excluding persons who had been hospitalized due to COVID-19; using multiple imputation; restricting cases to participants with ongoing symptoms; excluding PCC cases with only psychological, cognitive, or neurological symptoms; and additionally adjusting for vaccination status (eTable 4 in the Supplement). A weaker association was observed when we excluded participants endorsing fatigue or excluded alcohol intake from healthy lifestyle factors (eTable 5 in the Supplement). The association did not differ by health care worker status (eTable 6 in the Supplement, P = .77 for interaction).

Among participants who developed PCC, all COVID-19 symptoms were less prevalent in participants with higher healthy lifestyle scores, except for smell or taste problems and headache (0-4 factors, mean [SD] number of symptoms, 2.7 [1.8]; 5-6 factors, mean [SD] number of symptoms, 2.3 [1.6], Figure 2). Adherence to 5 to 6 vs 0 to 4 healthy lifestyle factors was associated with lower risk of daily life impairment due to PCC, although the CI was wide (RR, 0.70; 95% CI, 0.44-1.12).

Figure 2. — Healthy lifestyle factors include healthy body weight (body mass index, 18.5-24.9; calculated as weight in kilograms divided by height in meters squared), never smoking, at least 150 min/wk of moderate to vigorous physical activity, high diet quality (upper 40% of Alternative Healthy Eating Index [AHEI]–2010 score), moderate alcohol intake (5-15 g/d), and adequate sleep (7-9 h/d). Diet and alcohol intake were assessed in 2015; all other lifestyle factors were assessed in 2017.

Discussion

In this prospective cohort study of women followed up for more than a year starting in April 2020, we found a beneficial dose-response association of a preinfection healthy lifestyle with risk of PCC, after accounting for sociodemographic factors and pre-existing conditions. Women endorsing 5 or 6 healthy lifestyle factors had approximately 50% lower risk of PCC than those without any healthy lifestyle factors. These associations were mainly driven by healthy body weight and adequate sleep. The PAR for all 6 healthy lifestyle factors in combination was 36.0%, indicating that, if these associations were causal, 36.0% of PCC cases would have been avoided if all participants had 5 or 6 healthy lifestyle factors prior to the pandemic.

Few studies have examined modifiable lifestyle factors preceding the pandemic as risk factors for PCC. Adherence to a healthy lifestyle has been associated with reduced risk of noncommunicable diseases and mortality,^19,33 indicating a long-term health benefit. Specific to COVID-19, 2 prospective cohort studies using the UK Biobank (sample size approximately 400 000) found that a combination of lifestyle factors had a dose-response association with lower risk of COVID-19 hospitalization and mortality.^19,20 Unhealthy lifestyle factors (smoking, physical inactivity, obesity, and alcohol drinking) in combination accounted for 51% of severe COVID-19 in the United Kingdom population.²⁰ The associations between healthy lifestyle score and risk of severe COVID was partly mediated by low-grade inflammation (10% to 16%), as indicated by levels of C-reactive protein, although biomarkers were collected 10 years prior to infection.²⁰ Our findings additionally identified a dose-response protective association of a healthy lifestyle against development of PCC, independent of pre-existing conditions and severity of acute phase disease.

While our results suggest that each of the 6 healthy lifestyle factors measured were broadly associated with a lower risk of PCC, in analyses mutually adjusted for all lifestyle factors and comorbidities, BMI and sleep were most strongly associated with lower risk of PCC. Several individual lifestyle factors have been associated with risk of long-term COVID symptoms or slow recovery from COVID-19, including obesity, smoking, unhealthy diet, and poor-quality sleep,^{21,22,23,41,42,43} although findings were not consistent, and no studies to our knowledge mutually adjusted for a range of lifestyle factors.²³

Several biological mechanisms may explain the associations we observed. First, each unhealthy lifestyle factor we examined has been associated with increased risk of chronic inflammation, including findings from our cohort.^{13,14,15,16,17,18,20,44,45,46,47,48,49,50,51,52,53} Sustained systemic inflammation has been implicated in the development of PCC.⁹ Chronic inflammation may predispose individuals to excessive release of cytokines after infection, subsequently increasing risk for long-term complications in multiple organs.^54,55 Second, these unhealthy lifestyle factors dysregulate adaptive autoimmunity, which has been found in individuals with PCC.^{9,56,57,58,59,60} Third, unhealthy lifestyle factors (obesity, smoking, physical inactivity, and excessive alcohol intake) predispose to blood clotting abnormalities, another pathophysiological change observed in persons with PCC.^61,62 It has also been postulated that healthy lifestyle may benefit both innate and adaptive immune responses.^63,64,65

Strengths of our study include a prospective design in which healthy lifestyle factors were assessed prior to the pandemic using validated instruments. In addition, incident SARS-CoV-2 infection, hospitalization due to COVID-19, COVID-19 vaccination, and PCC were ascertained during an active phase of the pandemic with monthly and quarterly follow-up over 19 months. Our study provides valuable population-based evidence for the association between healthy lifestyle and PCC.

Limitations

Our study has several limitations. First, our cohort was comprised of middle-aged female nurses who were predominantly White, limiting generalizability. Moreover, because the incidence of PCC may differ by infecting strains,⁶⁶ we cannot be certain that associations we found apply to PCC resulting from subsequent COVID-19 strains. In addition, we do not have information about multiple infections. Second, PCC information was not missing at random, which might have introduced bias. However, results were comparable in analyses using multiple imputation. Third, as SARS-CoV-2 infection and PCC were self-reported, misclassification may have occurred. Nevertheless, validity of self-reported health information is high in this cohort. Fourth, because PCC is still poorly understood, and there is no reference standard (or consensus) for the diagnosis of PCC, it is practically difficult to link symptoms with COVID-19 and to ascertain PCC cases.⁶⁷ Finally, because asymptomatic cases are less likely to be detected, we likely underestimated the true prevalence of COVID-19 infections.

The findings for PAR should be interpreted with caution. The PAR relies on a causal interpretation of the association between healthy lifestyle factors and risk of PCC. As our study is observational, residual confounding likely remains, despite adjustment for multiple potential confounders. Although these healthy lifestyle factors are potentially modifiable, they are difficult to change;⁶⁸ thus, eliminating this PAR may not be achievable. In addition, PAR is a population-specific calculation contingent on the prevalence of the exposures and their association with risk of disease; thus, the PAR calculated here may not apply to other populations. However, the prevalence of healthy lifestyle factors was comparable in female participants of the same age in the nationally representative NHANES cohort.

Conclusions

The findings of this prospective cohort study indicate that adherence to a healthy lifestyle was associated with substantially reduced risk of developing PCC among individuals subsequently infected with SARS-CoV-2. If the associations we found were causal, among healthy lifestyle factors, maintaining a healthy weight and having adequate sleep duration may confer the greatest benefit for prevention of PCC. Future research should investigate whether implementing lifestyle interventions decreases risk of PCC or benefits persons with PCC or other chronic postinfection syndromes.

Supplement 1.

eFigure 1. Flowchart of COVID-19 substudy study design, the Nurses’ Health Study II (NHSII), 2015–2021

eFigure 2. Flowchart of study design, the Nurses’ Health Study II, 2015–2021

eMethods. Supplementary methods

eTable 1. Age-standardized characteristics according to missingness of post–COVID-19 condition (PCC) information, the Nurses’ Health Study II, 2015–2021

eTable 2. Correlation (phi coefficient) among healthy lifestyle factors prior to the pandemic among participants reported a positive SARS-CoV-2 test during follow up, the Nurses’ Health Study II, 2015–2021, n=1981

eTable 3. Healthy lifestyle factors and population attributable risk percentage of post–COVID-19 condition by prevalence of risk factors among women ages 55 to 75 years in the US National Health and Nutrition Examination Survey (NHANES, 2013–2014)

eTable 4. Healthy lifestyle factors prior to the pandemic and risk of post–COVID-19 condition (PCC) among participants who reported a positive SARS-CoV-2 test during follow up, the Nurses’ Health Study II, 2015–2021, n=1981

eTable 5. Healthy lifestyle factors excluding alcohol intake prior to the pandemic and risk of post–COVID-19 condition among participants who reported a positive SARS-CoV-2 test during follow up, the Nurses’ Health Study II, 2015–2021, n=1981

eTable 6. Healthy lifestyle factors prior to the pandemic and risk of post–COVID-19 condition among participants who reported a positive SARS-CoV-2 test during follow up, stratified by healthcare worker status, the Nurses’ Health Study II, 2015–2021, n=1981

Click here for additional data file.^{(353.8KB, pdf)}

Supplement 2.

Data Sharing Statement

Click here for additional data file.^{(17.1KB, pdf)}

References

1.Centers for Disease Control and Prevention . Long COVID or post-COVID conditions. Updated December 16, 2022. Accessed December 22, 2022. https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html
2.Centers for Disease Control and Prevention . Nearly one in five american adults who have had COVID-19 still have “long COVID.” June 22, 2022. Accessed December 22, 2022. https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2022/20220622.htm
3.Canada Go . COVID-19 for health professionals: post COVID-19 condition (long COVID). Updated October 20, 2022. Accessed December 22, 2022. https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/health-professionals/post-covid-19-condition.html
4.Iqbal FM, Lam K, Sounderajah V, Clarke JM, Ashrafian H, Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome: a systematic review and meta-analysis. EClinicalMedicine. 2021;36:100899. doi: 10.1016/j.eclinm.2021.100899 [DOI] [PMC free article] [PubMed] [Google Scholar]
5.Evans RA, McAuley H, Harrison EM, et al. ; PHOSP-COVID Collaborative Group . Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir Med. 2021;9(11):1275-1287. doi: 10.1016/S2213-2600(21)00383-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
6.Azzolini E, Levi R, Sarti R, et al. Association between BNT162b2 vaccination and long COVID after infections not requiring hospitalization in health care workers. JAMA. 2022;328(7):676-678. doi: 10.1001/jama.2022.11691 [DOI] [PMC free article] [PubMed] [Google Scholar]
7.Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601-615. doi: 10.1038/s41591-021-01283-z [DOI] [PMC free article] [PubMed] [Google Scholar]
8.U.S. Department of Health and Human Services . Biden–Harris administration releases two new reports on long COVID to support patients and further research. August 3, 2022. Accessed December 22, 2022. https://www.hhs.gov/about/news/2022/08/03/biden-harris-administration-releases-two-new-reports-long-covid-support-patients-further-research.html
9.Crook H, Raza S, Nowell J, Young M, Edison P. Long COVID—mechanisms, risk factors, and management. BMJ. 2021;374(1648):n1648. doi: 10.1136/bmj.n1648 [DOI] [PubMed] [Google Scholar]
10.Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol. 2022;23(2):194-202. doi: 10.1038/s41590-021-01104-y [DOI] [PMC free article] [PubMed] [Google Scholar]
11.Choutka J, Jansari V, Hornig M, Iwasaki A. Author correction: unexplained post-acute infection syndromes. Nat Med. 2022;28(8):1723. doi: 10.1038/s41591-022-01952-7 [DOI] [PubMed] [Google Scholar]
12.Behan PO, Behan WM, Gow JW, Cavanagh H, Gillespie S. Enteroviruses and postviral fatigue syndrome. Ciba Found Symp. 1993;173:146-154. doi: 10.1002/9780470514382.ch9 [DOI] [PubMed] [Google Scholar]
13.Monteiro R, Azevedo I. Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm. 2010;2010:289645. doi: 10.1155/2010/289645 [DOI] [PMC free article] [PubMed] [Google Scholar]
14.Lee J, Taneja V, Vassallo R. Cigarette smoking and inflammation: cellular and molecular mechanisms. J Dent Res. 2012;91(2):142-149. doi: 10.1177/0022034511421200 [DOI] [PMC free article] [PubMed] [Google Scholar]
15.Akbaraly TN, Shipley MJ, Ferrie JE, et al. Long-term adherence to healthy dietary guidelines and chronic inflammation in the prospective Whitehall II study. Am J Med. 2015;128(2):152-160.e4. doi: 10.1016/j.amjmed.2014.10.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
16.Imhof A, Froehlich M, Brenner H, Boeing H, Pepys MB, Koenig W. Effect of alcohol consumption on systemic markers of inflammation. Lancet. 2001;357(9258):763-767. doi: 10.1016/S0140-6736(00)04170-2 [DOI] [PubMed] [Google Scholar]
17.Beavers KM, Brinkley TE, Nicklas BJ. Effect of exercise training on chronic inflammation. Clin Chim Acta. 2010;411(11-12):785-793. doi: 10.1016/j.cca.2010.02.069 [DOI] [PMC free article] [PubMed] [Google Scholar]
18.Mullington JM, Simpson NS, Meier-Ewert HK, Haack M. Sleep loss and inflammation. Best Pract Res Clin Endocrinol Metab. 2010;24(5):775-784. doi: 10.1016/j.beem.2010.08.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
19.Ahmadi MN, Huang BH, Inan-Eroglu E, Hamer M, Stamatakis E. Lifestyle risk factors and infectious disease mortality, including COVID-19, among middle aged and older adults: evidence from a community-based cohort study in the United Kingdom. Brain Behav Immun. 2021;96:18-27. doi: 10.1016/j.bbi.2021.04.022 [DOI] [PMC free article] [PubMed] [Google Scholar]
20.Hamer M, Kivimäki M, Gale CR, Batty GD. Lifestyle risk factors, inflammatory mechanisms, and COVID-19 hospitalization: a community-based cohort study of 387,109 adults in UK. Brain Behav Immun. 2020;87:184-187. doi: 10.1016/j.bbi.2020.05.059 [DOI] [PMC free article] [PubMed] [Google Scholar]
21.Subramanian A, Nirantharakumar K, Hughes S, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28(8):1706-1714. doi: 10.1038/s41591-022-01909-w [DOI] [PMC free article] [PubMed] [Google Scholar]
22.Tenforde MW, Kim SS, Lindsell CJ, et al. ; IVY Network Investigators; CDC COVID-19 Response Team; IVY Network Investigators . Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network—United States, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993-998. doi: 10.15585/mmwr.mm6930e1 [DOI] [PMC free article] [PubMed] [Google Scholar]
23.Thompson EJ, Williams DM, Walker AJ, et al. ; OpenSAFELY Collaborative . Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. 2022;13(1):3528. doi: 10.1038/s41467-022-30836-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
24.Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626-631. doi: 10.1038/s41591-021-01292-y [DOI] [PMC free article] [PubMed] [Google Scholar]
25.Bao Y, Bertoia ML, Lenart EB, et al. Origin, methods, and evolution of the three Nurses’ Health Studies. Am J Public Health. 2016;106(9):1573-1581. doi: 10.2105/AJPH.2016.303338 [DOI] [PMC free article] [PubMed] [Google Scholar]
26.Troy LM, Hunter DJ, Manson JE, Colditz GA, Stampfer MJ, Willett WC. The validity of recalled weight among younger women. Int J Obes Relat Metab Disord. 1995;19(8):570-572. [PubMed] [Google Scholar]
27.Al-Delaimy WK, Willett WC. Measurement of tobacco smoke exposure: comparison of toenail nicotine biomarkers and self-reports. Cancer Epidemiol Biomarkers Prev. 2008;17(5):1255-1261. doi: 10.1158/1055-9965.EPI-07-2695 [DOI] [PubMed] [Google Scholar]
28.Yuan C, Spiegelman D, Rimm EB, et al. Validity of a dietary questionnaire assessed by comparison with multiple weighed dietary records or 24-hour recalls. Am J Epidemiol. 2017;185(7):570-584. doi: 10.1093/aje/kww104 [DOI] [PMC free article] [PubMed] [Google Scholar]
29.Yuan C, Spiegelman D, Rimm EB, et al. Relative validity of nutrient intakes assessed by questionnaire, 24-hour recalls, and diet records as compared with urinary recovery and plasma concentration biomarkers: findings for women. Am J Epidemiol. 2018;187(5):1051-1063. doi: 10.1093/aje/kwx328 [DOI] [PMC free article] [PubMed] [Google Scholar]
30.Chiuve SE, Fung TT, Rimm EB, et al. Alternative dietary indices both strongly predict risk of chronic disease. J Nutr. 2012;142(6):1009-1018. doi: 10.3945/jn.111.157222 [DOI] [PMC free article] [PubMed] [Google Scholar]
31.Wolf AM, Hunter DJ, Colditz GA, et al. Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol. 1994;23(5):991-999. doi: 10.1093/ije/23.5.991 [DOI] [PubMed] [Google Scholar]
32.Patel SR, Ayas NT, Malhotra MR, et al. A prospective study of sleep duration and mortality risk in women. Sleep. 2004;27(3):440-444. doi: 10.1093/sleep/27.3.440 [DOI] [PubMed] [Google Scholar]
33.Li Y, Pan A, Wang DD, et al. Impact of healthy lifestyle factors on life expectancies in the US population. Circulation. 2018;138(4):345-355. doi: 10.1161/CIRCULATIONAHA.117.032047 [DOI] [PMC free article] [PubMed] [Google Scholar]
34.World Health Organization . Body mass index (BMI). Accessed December 22, 2022. https://www.who.int/data/gho/data/themes/topics/topic-details/GHO/body-mass-index?introPage=intro_3.html
35.U.S. Department of Health and Human Services . Physical Activity Guidelines Advisory Committee. 2018. Accessed December 22, 2022. https://health.gov/our-work/nutrition-physical-activity/physical-activity-guidelines/current-guidelines/scientific-report
36.Watson NF, Badr MS, Belenky G, et al. ; Consensus Conference Panel . Joint Consensus Statement of the American Academy of Sleep Medicine and Sleep Research Society on the recommended amount of sleep for a healthy adult: methodology and discussion. Sleep. 2015;38(8):1161-1183. doi: 10.5665/sleep.4886 [DOI] [PMC free article] [PubMed] [Google Scholar]
37.Wang S, Quan L, Chavarro JE, et al. Associations of depression, anxiety, worry, perceived stress, and loneliness prior to infection with risk of post-COVID-19 conditions. JAMA Psychiatry. 2022;79(11):1081-1091. doi: 10.1001/jamapsychiatry.2022.2640 [DOI] [PMC free article] [PubMed] [Google Scholar]
38.Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. Wolters Kluwer Health/Lippincott Williams & Wilkins; 2008. [Google Scholar]
39.Chiva-Blanch G, Badimon L. Benefits and risks of moderate alcohol consumption on cardiovascular disease: current findings and controversies. Nutrients. 2019;12(1):108. doi: 10.3390/nu12010108 [DOI] [PMC free article] [PubMed] [Google Scholar]
40.Corrao G, Bagnardi V, Zambon A, La Vecchia C. A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med. 2004;38(5):613-619. doi: 10.1016/j.ypmed.2003.11.027 [DOI] [PubMed] [Google Scholar]
41.Cobre AF, Surek M, Vilhena RO, et al. Influence of foods and nutrients on COVID-19 recovery: a multivariate analysis of data from 170 countries using a generalized linear model. Clin Nutr. 2022;41(12):3077-3084. doi: 10.1016/j.clnu.2021.03.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
42.Yu W, Rohli KE, Yang S, Jia P. Impact of obesity on COVID-19 patients. J Diabetes Complications. 2021;35(3):107817. doi: 10.1016/j.jdiacomp.2020.107817 [DOI] [PMC free article] [PubMed] [Google Scholar]
43.Zhang J, Xu D, Xie B, et al. Poor-sleep is associated with slow recovery from lymphopenia and an increased need for ICU care in hospitalized patients with COVID-19: a retrospective cohort study. Brain Behav Immun. 2020;88:50-58. doi: 10.1016/j.bbi.2020.05.075 [DOI] [PMC free article] [PubMed] [Google Scholar]
44.Woods JA, Ceddia MA, Wolters BW, Evans JK, Lu Q, McAuley E. Effects of 6 months of moderate aerobic exercise training on immune function in the elderly. Mech Ageing Dev. 1999;109(1):1-19. doi: 10.1016/S0047-6374(99)00014-7 [DOI] [PubMed] [Google Scholar]
45.Molina PE, Happel KI, Zhang P, Kolls JK, Nelson S. Focus on: alcohol and the immune system. Alcohol Res Health. 2010;33(1-2):97-108. https://pubmed.ncbi.nlm.nih.gov/23579940/ [PMC free article] [PubMed] [Google Scholar]
46.Korakas E, Ikonomidis I, Kousathana F, et al. Obesity and COVID-19: immune and metabolic derangement as a possible link to adverse clinical outcomes. Am J Physiol Endocrinol Metab. 2020;319(1):E105-E109. doi: 10.1152/ajpendo.00198.2020 [DOI] [PMC free article] [PubMed] [Google Scholar]
47.Lee AC, Chakladar J, Li WT, et al. Tobacco, but not nicotine and flavor-less electronic cigarettes, induces ACE2 and immune dysregulation. Int J Mol Sci. 2020;21(15):5513. doi: 10.3390/ijms21155513 [DOI] [PMC free article] [PubMed] [Google Scholar]
48.Aldabal L, Bahammam AS. Metabolic, endocrine, and immune consequences of sleep deprivation. Open Respir Med J. 2011;5:31-43. doi: 10.2174/1874306401105010031 [DOI] [PMC free article] [PubMed] [Google Scholar]
49.Childs CE, Calder PC, Miles EA. Diet and immune function. Nutrients. 2019;11(8):1933. doi: 10.3390/nu11081933 [DOI] [PMC free article] [PubMed] [Google Scholar]
50.Pischon T, Hankinson SE, Hotamisligil GS, Rifai N, Rimm EB. Leisure-time physical activity and reduced plasma levels of obesity-related inflammatory markers. Obes Res. 2003;11(9):1055-1064. doi: 10.1038/oby.2003.145 [DOI] [PubMed] [Google Scholar]
51.Lu B, Solomon DH, Costenbader KH, Keenan BT, Chibnik LB, Karlson EW. Alcohol consumption and markers of inflammation in women with preclinical rheumatoid arthritis. Arthritis Rheum. 2010;62(12):3554-3559. doi: 10.1002/art.27739 [DOI] [PMC free article] [PubMed] [Google Scholar]
52.Huang T, Tobias DK, Hruby A, Rifai N, Tworoger SS, Hu FB. An increase in dietary quality is associated with favorable plasma biomarkers of the brain-adipose axis in apparently healthy US women. J Nutr. 2016;146(5):1101-1108. doi: 10.3945/jn.115.229666 [DOI] [PMC free article] [PubMed] [Google Scholar]
53.Huang T, Goodman M, Li X, et al. C-reactive protein and risk of OSA in four US cohorts. Chest. 2021;159(6):2439-2448. doi: 10.1016/j.chest.2021.01.060 [DOI] [PMC free article] [PubMed] [Google Scholar]
54.Lim S, Bae JH, Kwon HS, Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol. 2021;17(1):11-30. doi: 10.1038/s41574-020-00435-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
55.Khunti K, Davies MJ, Kosiborod MN, Nauck MA. Long COVID—metabolic risk factors and novel therapeutic management. Nat Rev Endocrinol. 2021;17(7):379-380. doi: 10.1038/s41574-021-00495-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
56.Versini M, Jeandel PY, Rosenthal E, Shoenfeld Y. Obesity in autoimmune diseases: not a passive bystander. Autoimmun Rev. 2014;13(9):981-1000. doi: 10.1016/j.autrev.2014.07.001 [DOI] [PubMed] [Google Scholar]
57.Zielinski MR, Systrom DM, Rose NR. Fatigue, sleep, and autoimmune and related disorders. Front Immunol. 2019;10:1827. doi: 10.3389/fimmu.2019.01827 [DOI] [PMC free article] [PubMed] [Google Scholar]
58.Costenbader KH, Karlson EW. Cigarette smoking and autoimmune disease: what can we learn from epidemiology? Lupus. 2006;15(11):737-745. doi: 10.1177/0961203306069344 [DOI] [PubMed] [Google Scholar]
59.Manzel A, Muller DN, Hafler DA, Erdman SE, Linker RA, Kleinewietfeld M. Role of “Western diet” in inflammatory autoimmune diseases. Curr Allergy Asthma Rep. 2014;14(1):404. doi: 10.1007/s11882-013-0404-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
60.Pinto AJ, Roschel H, de Sá Pinto AL, et al. Physical inactivity and sedentary behavior: overlooked risk factors in autoimmune rheumatic diseases? Autoimmun Rev. 2017;16(7):667-674. doi: 10.1016/j.autrev.2017.05.001 [DOI] [PubMed] [Google Scholar]
61.Prasannan N, Heightman M, Hillman T, et al. Impaired exercise capacity in post-COVID-19 syndrome: the role of VWF-ADAMTS13 axis. Blood Adv. 2022;6(13):4041-4048. doi: 10.1182/bloodadvances.2021006944 [DOI] [PMC free article] [PubMed] [Google Scholar]
62.Goldhaber SZ, Fanikos J. Cardiology patient pages: prevention of deep vein thrombosis and pulmonary embolism. Circulation. 2004;110(16):e445-e447. doi: 10.1161/01.CIR.0000145141.70264.C5 [DOI] [PubMed] [Google Scholar]
63.Stämpfli MR, Anderson GP. How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nat Rev Immunol. 2009;9(5):377-384. doi: 10.1038/nri2530 [DOI] [PubMed] [Google Scholar]
64.Ibarra-Coronado EG, Pantaleón-Martínez AM, Velazquéz-Moctezuma J, et al. The bidirectional relationship between sleep and immunity against infections. J Immunol Res. 2015;2015:678164. doi: 10.1155/2015/678164 [DOI] [PMC free article] [PubMed] [Google Scholar]
65.Milner JJ, Beck MA. The impact of obesity on the immune response to infection. Proc Nutr Soc. 2012;71(2):298-306. doi: 10.1017/S0029665112000158 [DOI] [PMC free article] [PubMed] [Google Scholar]
66.Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399(10343):2263-2264. doi: 10.1016/S0140-6736(22)00941-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
67.Munblit D, O’Hara ME, Akrami A, Perego E, Olliaro P, Needham DM. Long COVID: aiming for a consensus. Lancet Respir Med. 2022;10(7):632-634. doi: 10.1016/S2213-2600(22)00135-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
68.Bouton ME. Why behavior change is difficult to sustain. Prev Med. 2014;68:29-36. doi: 10.1016/j.ypmed.2014.06.010 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplement 1.

eFigure 1. Flowchart of COVID-19 substudy study design, the Nurses’ Health Study II (NHSII), 2015–2021

eFigure 2. Flowchart of study design, the Nurses’ Health Study II, 2015–2021

eMethods. Supplementary methods

eTable 1. Age-standardized characteristics according to missingness of post–COVID-19 condition (PCC) information, the Nurses’ Health Study II, 2015–2021

Click here for additional data file.^{(353.8KB, pdf)}

Supplement 2.

Data Sharing Statement

Click here for additional data file.^{(17.1KB, pdf)}

[ioi220085r1] 1.Centers for Disease Control and Prevention . Long COVID or post-COVID conditions. Updated December 16, 2022. Accessed December 22, 2022. https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html

[ioi220085r2] 2.Centers for Disease Control and Prevention . Nearly one in five american adults who have had COVID-19 still have “long COVID.” June 22, 2022. Accessed December 22, 2022. https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2022/20220622.htm

[ioi220085r3] 3.Canada Go . COVID-19 for health professionals: post COVID-19 condition (long COVID). Updated October 20, 2022. Accessed December 22, 2022. https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/health-professionals/post-covid-19-condition.html

[ioi220085r4] 4.Iqbal FM, Lam K, Sounderajah V, Clarke JM, Ashrafian H, Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome: a systematic review and meta-analysis. EClinicalMedicine. 2021;36:100899. doi: 10.1016/j.eclinm.2021.100899 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r5] 5.Evans RA, McAuley H, Harrison EM, et al. ; PHOSP-COVID Collaborative Group . Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir Med. 2021;9(11):1275-1287. doi: 10.1016/S2213-2600(21)00383-0 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r6] 6.Azzolini E, Levi R, Sarti R, et al. Association between BNT162b2 vaccination and long COVID after infections not requiring hospitalization in health care workers. JAMA. 2022;328(7):676-678. doi: 10.1001/jama.2022.11691 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r7] 7.Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601-615. doi: 10.1038/s41591-021-01283-z [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r8] 8.U.S. Department of Health and Human Services . Biden–Harris administration releases two new reports on long COVID to support patients and further research. August 3, 2022. Accessed December 22, 2022. https://www.hhs.gov/about/news/2022/08/03/biden-harris-administration-releases-two-new-reports-long-covid-support-patients-further-research.html

[ioi220085r9] 9.Crook H, Raza S, Nowell J, Young M, Edison P. Long COVID—mechanisms, risk factors, and management. BMJ. 2021;374(1648):n1648. doi: 10.1136/bmj.n1648 [DOI] [PubMed] [Google Scholar]

[ioi220085r10] 10.Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol. 2022;23(2):194-202. doi: 10.1038/s41590-021-01104-y [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r11] 11.Choutka J, Jansari V, Hornig M, Iwasaki A. Author correction: unexplained post-acute infection syndromes. Nat Med. 2022;28(8):1723. doi: 10.1038/s41591-022-01952-7 [DOI] [PubMed] [Google Scholar]

[ioi220085r12] 12.Behan PO, Behan WM, Gow JW, Cavanagh H, Gillespie S. Enteroviruses and postviral fatigue syndrome. Ciba Found Symp. 1993;173:146-154. doi: 10.1002/9780470514382.ch9 [DOI] [PubMed] [Google Scholar]

[ioi220085r13] 13.Monteiro R, Azevedo I. Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm. 2010;2010:289645. doi: 10.1155/2010/289645 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r14] 14.Lee J, Taneja V, Vassallo R. Cigarette smoking and inflammation: cellular and molecular mechanisms. J Dent Res. 2012;91(2):142-149. doi: 10.1177/0022034511421200 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r15] 15.Akbaraly TN, Shipley MJ, Ferrie JE, et al. Long-term adherence to healthy dietary guidelines and chronic inflammation in the prospective Whitehall II study. Am J Med. 2015;128(2):152-160.e4. doi: 10.1016/j.amjmed.2014.10.002 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r16] 16.Imhof A, Froehlich M, Brenner H, Boeing H, Pepys MB, Koenig W. Effect of alcohol consumption on systemic markers of inflammation. Lancet. 2001;357(9258):763-767. doi: 10.1016/S0140-6736(00)04170-2 [DOI] [PubMed] [Google Scholar]

[ioi220085r17] 17.Beavers KM, Brinkley TE, Nicklas BJ. Effect of exercise training on chronic inflammation. Clin Chim Acta. 2010;411(11-12):785-793. doi: 10.1016/j.cca.2010.02.069 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r18] 18.Mullington JM, Simpson NS, Meier-Ewert HK, Haack M. Sleep loss and inflammation. Best Pract Res Clin Endocrinol Metab. 2010;24(5):775-784. doi: 10.1016/j.beem.2010.08.014 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r19] 19.Ahmadi MN, Huang BH, Inan-Eroglu E, Hamer M, Stamatakis E. Lifestyle risk factors and infectious disease mortality, including COVID-19, among middle aged and older adults: evidence from a community-based cohort study in the United Kingdom. Brain Behav Immun. 2021;96:18-27. doi: 10.1016/j.bbi.2021.04.022 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r20] 20.Hamer M, Kivimäki M, Gale CR, Batty GD. Lifestyle risk factors, inflammatory mechanisms, and COVID-19 hospitalization: a community-based cohort study of 387,109 adults in UK. Brain Behav Immun. 2020;87:184-187. doi: 10.1016/j.bbi.2020.05.059 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r21] 21.Subramanian A, Nirantharakumar K, Hughes S, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28(8):1706-1714. doi: 10.1038/s41591-022-01909-w [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r22] 22.Tenforde MW, Kim SS, Lindsell CJ, et al. ; IVY Network Investigators; CDC COVID-19 Response Team; IVY Network Investigators . Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network—United States, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993-998. doi: 10.15585/mmwr.mm6930e1 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r23] 23.Thompson EJ, Williams DM, Walker AJ, et al. ; OpenSAFELY Collaborative . Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. 2022;13(1):3528. doi: 10.1038/s41467-022-30836-0 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r24] 24.Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626-631. doi: 10.1038/s41591-021-01292-y [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r25] 25.Bao Y, Bertoia ML, Lenart EB, et al. Origin, methods, and evolution of the three Nurses’ Health Studies. Am J Public Health. 2016;106(9):1573-1581. doi: 10.2105/AJPH.2016.303338 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r26] 26.Troy LM, Hunter DJ, Manson JE, Colditz GA, Stampfer MJ, Willett WC. The validity of recalled weight among younger women. Int J Obes Relat Metab Disord. 1995;19(8):570-572. [PubMed] [Google Scholar]

[ioi220085r27] 27.Al-Delaimy WK, Willett WC. Measurement of tobacco smoke exposure: comparison of toenail nicotine biomarkers and self-reports. Cancer Epidemiol Biomarkers Prev. 2008;17(5):1255-1261. doi: 10.1158/1055-9965.EPI-07-2695 [DOI] [PubMed] [Google Scholar]

[ioi220085r28] 28.Yuan C, Spiegelman D, Rimm EB, et al. Validity of a dietary questionnaire assessed by comparison with multiple weighed dietary records or 24-hour recalls. Am J Epidemiol. 2017;185(7):570-584. doi: 10.1093/aje/kww104 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r29] 29.Yuan C, Spiegelman D, Rimm EB, et al. Relative validity of nutrient intakes assessed by questionnaire, 24-hour recalls, and diet records as compared with urinary recovery and plasma concentration biomarkers: findings for women. Am J Epidemiol. 2018;187(5):1051-1063. doi: 10.1093/aje/kwx328 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r30] 30.Chiuve SE, Fung TT, Rimm EB, et al. Alternative dietary indices both strongly predict risk of chronic disease. J Nutr. 2012;142(6):1009-1018. doi: 10.3945/jn.111.157222 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r31] 31.Wolf AM, Hunter DJ, Colditz GA, et al. Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol. 1994;23(5):991-999. doi: 10.1093/ije/23.5.991 [DOI] [PubMed] [Google Scholar]

[ioi220085r32] 32.Patel SR, Ayas NT, Malhotra MR, et al. A prospective study of sleep duration and mortality risk in women. Sleep. 2004;27(3):440-444. doi: 10.1093/sleep/27.3.440 [DOI] [PubMed] [Google Scholar]

[ioi220085r33] 33.Li Y, Pan A, Wang DD, et al. Impact of healthy lifestyle factors on life expectancies in the US population. Circulation. 2018;138(4):345-355. doi: 10.1161/CIRCULATIONAHA.117.032047 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r34] 34.World Health Organization . Body mass index (BMI). Accessed December 22, 2022. https://www.who.int/data/gho/data/themes/topics/topic-details/GHO/body-mass-index?introPage=intro_3.html

[ioi220085r35] 35.U.S. Department of Health and Human Services . Physical Activity Guidelines Advisory Committee. 2018. Accessed December 22, 2022. https://health.gov/our-work/nutrition-physical-activity/physical-activity-guidelines/current-guidelines/scientific-report

[ioi220085r36] 36.Watson NF, Badr MS, Belenky G, et al. ; Consensus Conference Panel . Joint Consensus Statement of the American Academy of Sleep Medicine and Sleep Research Society on the recommended amount of sleep for a healthy adult: methodology and discussion. Sleep. 2015;38(8):1161-1183. doi: 10.5665/sleep.4886 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r37] 37.Wang S, Quan L, Chavarro JE, et al. Associations of depression, anxiety, worry, perceived stress, and loneliness prior to infection with risk of post-COVID-19 conditions. JAMA Psychiatry. 2022;79(11):1081-1091. doi: 10.1001/jamapsychiatry.2022.2640 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r38] 38.Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. Wolters Kluwer Health/Lippincott Williams & Wilkins; 2008. [Google Scholar]

[ioi220085r39] 39.Chiva-Blanch G, Badimon L. Benefits and risks of moderate alcohol consumption on cardiovascular disease: current findings and controversies. Nutrients. 2019;12(1):108. doi: 10.3390/nu12010108 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r40] 40.Corrao G, Bagnardi V, Zambon A, La Vecchia C. A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med. 2004;38(5):613-619. doi: 10.1016/j.ypmed.2003.11.027 [DOI] [PubMed] [Google Scholar]

[ioi220085r41] 41.Cobre AF, Surek M, Vilhena RO, et al. Influence of foods and nutrients on COVID-19 recovery: a multivariate analysis of data from 170 countries using a generalized linear model. Clin Nutr. 2022;41(12):3077-3084. doi: 10.1016/j.clnu.2021.03.018 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r42] 42.Yu W, Rohli KE, Yang S, Jia P. Impact of obesity on COVID-19 patients. J Diabetes Complications. 2021;35(3):107817. doi: 10.1016/j.jdiacomp.2020.107817 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r43] 43.Zhang J, Xu D, Xie B, et al. Poor-sleep is associated with slow recovery from lymphopenia and an increased need for ICU care in hospitalized patients with COVID-19: a retrospective cohort study. Brain Behav Immun. 2020;88:50-58. doi: 10.1016/j.bbi.2020.05.075 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r44] 44.Woods JA, Ceddia MA, Wolters BW, Evans JK, Lu Q, McAuley E. Effects of 6 months of moderate aerobic exercise training on immune function in the elderly. Mech Ageing Dev. 1999;109(1):1-19. doi: 10.1016/S0047-6374(99)00014-7 [DOI] [PubMed] [Google Scholar]

[ioi220085r45] 45.Molina PE, Happel KI, Zhang P, Kolls JK, Nelson S. Focus on: alcohol and the immune system. Alcohol Res Health. 2010;33(1-2):97-108. https://pubmed.ncbi.nlm.nih.gov/23579940/ [PMC free article] [PubMed] [Google Scholar]

[ioi220085r46] 46.Korakas E, Ikonomidis I, Kousathana F, et al. Obesity and COVID-19: immune and metabolic derangement as a possible link to adverse clinical outcomes. Am J Physiol Endocrinol Metab. 2020;319(1):E105-E109. doi: 10.1152/ajpendo.00198.2020 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r47] 47.Lee AC, Chakladar J, Li WT, et al. Tobacco, but not nicotine and flavor-less electronic cigarettes, induces ACE2 and immune dysregulation. Int J Mol Sci. 2020;21(15):5513. doi: 10.3390/ijms21155513 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r48] 48.Aldabal L, Bahammam AS. Metabolic, endocrine, and immune consequences of sleep deprivation. Open Respir Med J. 2011;5:31-43. doi: 10.2174/1874306401105010031 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r49] 49.Childs CE, Calder PC, Miles EA. Diet and immune function. Nutrients. 2019;11(8):1933. doi: 10.3390/nu11081933 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r50] 50.Pischon T, Hankinson SE, Hotamisligil GS, Rifai N, Rimm EB. Leisure-time physical activity and reduced plasma levels of obesity-related inflammatory markers. Obes Res. 2003;11(9):1055-1064. doi: 10.1038/oby.2003.145 [DOI] [PubMed] [Google Scholar]

[ioi220085r51] 51.Lu B, Solomon DH, Costenbader KH, Keenan BT, Chibnik LB, Karlson EW. Alcohol consumption and markers of inflammation in women with preclinical rheumatoid arthritis. Arthritis Rheum. 2010;62(12):3554-3559. doi: 10.1002/art.27739 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r52] 52.Huang T, Tobias DK, Hruby A, Rifai N, Tworoger SS, Hu FB. An increase in dietary quality is associated with favorable plasma biomarkers of the brain-adipose axis in apparently healthy US women. J Nutr. 2016;146(5):1101-1108. doi: 10.3945/jn.115.229666 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r53] 53.Huang T, Goodman M, Li X, et al. C-reactive protein and risk of OSA in four US cohorts. Chest. 2021;159(6):2439-2448. doi: 10.1016/j.chest.2021.01.060 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r54] 54.Lim S, Bae JH, Kwon HS, Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol. 2021;17(1):11-30. doi: 10.1038/s41574-020-00435-4 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r55] 55.Khunti K, Davies MJ, Kosiborod MN, Nauck MA. Long COVID—metabolic risk factors and novel therapeutic management. Nat Rev Endocrinol. 2021;17(7):379-380. doi: 10.1038/s41574-021-00495-0 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r56] 56.Versini M, Jeandel PY, Rosenthal E, Shoenfeld Y. Obesity in autoimmune diseases: not a passive bystander. Autoimmun Rev. 2014;13(9):981-1000. doi: 10.1016/j.autrev.2014.07.001 [DOI] [PubMed] [Google Scholar]

[ioi220085r57] 57.Zielinski MR, Systrom DM, Rose NR. Fatigue, sleep, and autoimmune and related disorders. Front Immunol. 2019;10:1827. doi: 10.3389/fimmu.2019.01827 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r58] 58.Costenbader KH, Karlson EW. Cigarette smoking and autoimmune disease: what can we learn from epidemiology? Lupus. 2006;15(11):737-745. doi: 10.1177/0961203306069344 [DOI] [PubMed] [Google Scholar]

[ioi220085r59] 59.Manzel A, Muller DN, Hafler DA, Erdman SE, Linker RA, Kleinewietfeld M. Role of “Western diet” in inflammatory autoimmune diseases. Curr Allergy Asthma Rep. 2014;14(1):404. doi: 10.1007/s11882-013-0404-6 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r60] 60.Pinto AJ, Roschel H, de Sá Pinto AL, et al. Physical inactivity and sedentary behavior: overlooked risk factors in autoimmune rheumatic diseases? Autoimmun Rev. 2017;16(7):667-674. doi: 10.1016/j.autrev.2017.05.001 [DOI] [PubMed] [Google Scholar]

[ioi220085r61] 61.Prasannan N, Heightman M, Hillman T, et al. Impaired exercise capacity in post-COVID-19 syndrome: the role of VWF-ADAMTS13 axis. Blood Adv. 2022;6(13):4041-4048. doi: 10.1182/bloodadvances.2021006944 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r62] 62.Goldhaber SZ, Fanikos J. Cardiology patient pages: prevention of deep vein thrombosis and pulmonary embolism. Circulation. 2004;110(16):e445-e447. doi: 10.1161/01.CIR.0000145141.70264.C5 [DOI] [PubMed] [Google Scholar]

[ioi220085r63] 63.Stämpfli MR, Anderson GP. How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nat Rev Immunol. 2009;9(5):377-384. doi: 10.1038/nri2530 [DOI] [PubMed] [Google Scholar]

[ioi220085r64] 64.Ibarra-Coronado EG, Pantaleón-Martínez AM, Velazquéz-Moctezuma J, et al. The bidirectional relationship between sleep and immunity against infections. J Immunol Res. 2015;2015:678164. doi: 10.1155/2015/678164 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r65] 65.Milner JJ, Beck MA. The impact of obesity on the immune response to infection. Proc Nutr Soc. 2012;71(2):298-306. doi: 10.1017/S0029665112000158 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r66] 66.Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399(10343):2263-2264. doi: 10.1016/S0140-6736(22)00941-2 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r67] 67.Munblit D, O’Hara ME, Akrami A, Perego E, Olliaro P, Needham DM. Long COVID: aiming for a consensus. Lancet Respir Med. 2022;10(7):632-634. doi: 10.1016/S2213-2600(22)00135-7 [DOI] [PMC free article] [PubMed] [Google Scholar]

[ioi220085r68] 68.Bouton ME. Why behavior change is difficult to sustain. Prev Med. 2014;68:29-36. doi: 10.1016/j.ypmed.2014.06.010 [DOI] [PMC free article] [PubMed] [Google Scholar]

PERMALINK

Adherence to Healthy Lifestyle Prior to Infection and Risk of Post–COVID-19 Condition

Siwen Wang, MD

Yanping Li, PhD

Yiyang Yue, MS

Changzheng Yuan, ScD

Jae Hee Kang, ScD

Jorge E Chavarro, MD, ScD

Shilpa N Bhupathiraju, PhD

Andrea L Roberts, PhD

Key Points

Question

Findings

Meaning

Abstract

Importance

Objective

Design, Setting, and Participants

Main Outcomes and Measures

Results

Conclusions and Relevance

Introduction

Methods

Assessment of Healthy Lifestyle

Healthy Lifestyle Score

SARS-CoV-2 Infection and PCC

Covariates

Statistical Analysis

Results

Table 1. Age-Standardized Participant Characteristics by Number of Healthy Lifestyle Factors Prior to the Pandemic Among Participants Who Reported a Positive SARS-CoV-2 Test During Follow-up, the Nurses’ Health Study II, 2015-2021a.

Figure 1. Number of Healthy Lifestyle Factors Prior to the Pandemic and Risk of Post–COVID-19 Condition (PCC) Among Participants Who Reported a Positive SARS-CoV-2 Test During Follow-up, the Nurses’ Health Study II, 2015-2021.

Table 2. Healthy Lifestyle Factors Prior to the Pandemic and Risk of Post–COVID-19 Condition (PCC) Among Participants Who Reported a Positive SARS-CoV-2 Test During Follow-up, the Nurses’ Health Study II, 2015-2021.

Table 3. Dichotomized Healthy Lifestyle Factors Prior to the Pandemic and Risk of Post–COVID-19 Condition (PCC) Among Participants Who Reported a Positive SARS-CoV-2 Test During Follow-up, the Nurses’ Health Study II, 2015-2021.

Figure 2. Post–COVID-19 Condition (PCC) Symptoms According to Number of Healthy Lifestyle Factors Prior to the Pandemic Among Persons Who Developed PCC, the Nurses’ Health Study II, 2015-2021.

Discussion

Limitations

Conclusions

References

Associated Data

Supplementary Materials

ACTIONS

PERMALINK

RESOURCES

Similar articles

Cited by other articles

Links to NCBI Databases

Table 1. Age-Standardized Participant Characteristics by Number of Healthy Lifestyle Factors Prior to the Pandemic Among Participants Who Reported a Positive SARS-CoV-2 Test During Follow-up, the Nurses’ Health Study II, 2015-2021^a.